Search research articles
Contact Us
Filters
Showing results (41-50 of 124) with videos related to
Page
of 13
Sort By:
Journal of Neurology
|
December 24, 2017
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
Jessica Frau, Luisa Maria Villar, Claudia Sardu, et al.
Journal of Neuroimmunology
|
November 15, 2019
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis
Milena Nasi, Elena Bianchini, Sara De Biasi, et al.
Journal of Translational Medicine
|
April 18, 2020
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
Marco Chiarini, Ruggero Capra, Federico Serana, et al.
European Journal of Immunology
|
August 3, 2019
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients
Sara De Biasi, Anna Maria Simone, Elena Bianchini, et al.
Current Medical Research and Opinion
|
May 17, 2014
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study
Eleonora Baldi, Angelica Guareschi, Francesca Vitetta, et al.
Journal of Neuroimmunology
|
May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgG
Riccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
Aurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Nature Communications
|
March 30, 2024
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, et al.
Molecular and Cellular Neurosciences
|
August 24, 2020
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia
Milena Nasi, Anna De Gaetano, Elena Bianchini, et al.
Journal of Neurology
|
December 24, 2025
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study)
Clara Grazia Chisari, Salvatore Lo Fermo, Alessia Di Sapio, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 124) with videos related to
Sort By:
Page
of 13
Journal of Neurology
|
December 24, 2017
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
Jessica Frau, Luisa Maria Villar, Claudia Sardu, et al.
Journal of Neuroimmunology
|
November 15, 2019
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis
Milena Nasi, Elena Bianchini, Sara De Biasi, et al.
Journal of Translational Medicine
|
April 18, 2020
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
Marco Chiarini, Ruggero Capra, Federico Serana, et al.
European Journal of Immunology
|
August 3, 2019
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients
Sara De Biasi, Anna Maria Simone, Elena Bianchini, et al.
Current Medical Research and Opinion
|
May 17, 2014
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study
Eleonora Baldi, Angelica Guareschi, Francesca Vitetta, et al.
Journal of Neuroimmunology
|
May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgG
Riccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
Aurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Nature Communications
|
March 30, 2024
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, et al.
Molecular and Cellular Neurosciences
|
August 24, 2020
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia
Milena Nasi, Anna De Gaetano, Elena Bianchini, et al.
Journal of Neurology
|
December 24, 2025
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study)
Clara Grazia Chisari, Salvatore Lo Fermo, Alessia Di Sapio, et al.
Page
of 13